According to the latest study on “Small Molecule Drug Discovery Market Forecast to 2027– COVID-19 Impact and Global Analysis by Therapeutic Area and Process/Phase”, the global small molecule drug discovery market was valued at US$ 24,976.14 million in 2019 and is projected to reach US$ 50,823.06 million by 2027; it is expected to grow at a CAGR of 9.5% during 2020–2027. The report highlights trends prevailing in the global small molecule drug discovery market and the factors driving market along with those that act as hindrances.
Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis –
https://www.theinsightpartners.com/sample/TIPRE00004774/
Pfizer Inc., Bristol-Myers Squibb Company, Merck KGaA, GlaxoSmithKline Plc, AstraZeneca, Johnson & Johnson Services, Inc., Teva Pharmaceutical Industries Ltd, Boehringer Ingelheim International GmbH, and Allergan Plc are among the leading companies operating in the small molecule drug discovery market.
Based on therapeutic area, the global small molecule drug discovery market is segmented into oncology, central nervous system, cardiovascular, respiratory, orthopedics, immunology, rare diseases, and other therapeutic areas. The oncology cells segment held a largest share of the market in 2019; however, the rare diseases segment is estimated to register a higher CAGR during the forecast period owing to increasing prevalence of rare diseases, research activities and collaborations among market players. Some of the rare diseases are Hutchinson-Gilford Progeria, Fibrodysplasia Ossificans Progressiva, Microcephaly, Morgellons, and others.
Click here to avail lucrative discounts on our latest reports. We offer student, enterprise, and special periodic discounts to our clientele. Please fill the inquiry form below to know more –
https://www.theinsightpartners.com/discount/TIPRE00004774/
The small molecule drug discovery market is expected to grow owing to factors such as increasing approval of small molecule drugs, growing demand for R&D from contract organizations, and rising adoption of small molecules in chronic disease treatments. However, high drug development cost is likely to restrain the growth of the market during the forecast period.
The report segments global small molecule drug discovery market as follows:
By Therapeutic Area
- Oncology
- Central Nervous System
- Cardiovascular
- Respiratory
- Orthopedics
- Immunology
- Rare Diseases
- Other Therapeutic Areas
By Process/Phase
- Target Discovery
- Target Validation
- Lead Generation and Refinement
- Preclinical Development
By Geography
- North America
- US
- Canada
- Mexico
- Europe
- France
- Germany
- UK
- Spain
- Italy
- Asia Pacific (APAC)
- China
- India
- Japan
- Australia
- South Korea
- Middle East and Africa (MEA)
- Saudi Arabia
- UAE
- South Africa
- South and Central America (SCAM)
- Brazil
- Argentina
Immediate delivery of our off-the-shelf reports and prebooking of upcoming studies, through flexible and convenient payment methods –
https://www.theinsightpartners.com/buy/TIPRE00004774/
About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense, Food & beverage, Chemical and Materials, Semiconductors etc.
Contact Us:
Call: +1-646-491-9876
Email: sales@theinsightpartners.com
0